Corrections

Corrections log

Public record of every material editorial correction to the site.

Public log48-hr review SLAMaterial changes only
SS
Editorial team
Dr. Terra Walman, M.D. · Lead Medical Researcher
Reviewed by Joseph Safer, M.D. (Editor) · Last updated 2026-05-20

Recent corrections

May 20, 2026

How to submit a correction

  1. Email semaglutideglpone@gmail.com with "Correction" in the subject line.
  2. Include the URL of the page in question.
  3. Quote the specific text you believe is inaccurate.
  4. State what you believe is correct.
  5. Provide a primary source (FDA document, peer-reviewed publication, state license record, etc.) supporting the correction.

What happens after you submit

What counts as "material"

Material corrections are: any change to a clinical claim (mechanism, dosing, contraindication, drug interaction, trial outcome); any change to a pricing claim; any change to a provider scoring decision; any change to a pharmacy or Medical Director claim; any change to an FDA regulatory claim. Material corrections always get a public log entry here.

Non-material updates are: typos, broken links, formatting cleanups, image alt-text fixes. These are made silently as part of normal editorial maintenance.

Re-scoring after a provider claim changes

When a reviewed provider's claim changes — new Medical Director named, new pharmacy partner added, pricing changed, new transparency document published — the provider may submit the change for re-scoring at the same editorial inbox. Re-scoring is conducted by the Lead Medical Researcher with Editor review and normally completes within 14 days. Score changes are logged here (this page) and reflected in llms.txt within the same week.

Historical corrections

Corrections logged prior to May 20, 2026 are preserved at the URL paths they were originally logged at (within editorial-standards.html). This page becomes the canonical corrections record going forward.